This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Tri-Pharma, Inc., a minority-owned small disadvantaged business, for the delivery of 3,756 bottles of Buspirone HCL 5MG tablets. The $657,300 firm-fixed-price contract was awarded on May 21, 2019 with a completion date of June 10, 2019. The contract was awarded under the VA's Consolidated Mail Out-Patient Pharmacy (CMOP) program, which provides mail-order pharmacy services to veterans. There was no set-aside designation for this contract. Tri-Pharma, a specialty pharmaceutical wholesaler, has provided various pharmaceutical products and medical supplies to the VA and other government agencies in the past.